According to the U.S. health agency, Glenmark Pharmaceuticals is recalling over 15 lakh bottles of a generic drug used to ...

Glenmark’s Acetylcysteine Injection (DEL) is approved based on the safety and efficacy derived from the reference drug ...

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

Maruti Suzuki recorded slight growth, whereas Hyundai and Tata Motors experienced a drop in sales in February, as market ...

The Nifty Pharma index closed on a positive note on Monday. Shares of Natco Pharma Ltd.(up 3.24 per cent), Glenmark ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...

In February 2023, the Nifty saw its steepest fall since the Covid pandemic, dropping 6%. IT, auto, and pharma stocks faced ...

Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh ...

Glenmark Pharmaceuticals added 1.06% to Rs 1292.35 after the US-based subsidiary, Glenmark Pharmaceuticals Inc., USA announced the acquisition and launched of Acetylcysteine Injection, single-dose ...

This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an ...

Glenmark Pharma acquires and launches acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials: Our Bureau, Mumbai Monday, March 3, 2025, 12:15 Hrs [IST] Glenmark Pharma ...

Glenmark Pharmaceuticals acquires and launches Acetylcysteine Injection in the US market, strengthening its injectable ...